Impact of pre-amplification conditions on sensitivity of the tat/rev induced limiting dilution assay View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-06-07

AUTHORS

Liam Châtel, Xuefen Yang, François Cholette, Hugo Soudeyns, Paul Sandstrom, Carole Lavigne

ABSTRACT

Antiretroviral therapy (ART) can lower a patient’s HIV plasma viral load to an undetectable level, but following cessation of ART viremia rapidly rebounds. It has been shown that ART does not eliminate latent viruses sequestered into anatomical and cellular reservoirs. Therefore, in patients that have ceased ART, the following rebound in HIV viremia is caused by the activation of latent HIV reservoirs. A major issue in HIV cure research is the quantification of these latent HIV reservoirs. Various reservoir measurement methods exist, but the gold standard technique remains the culture-based quantitative viral outgrowth assay (QVOA). Recently, a new PCR-based assay, named the tat/rev induced limiting dilution assay (TILDA) was described which measures the frequency of inducible latently infected CD4+ T cells that actively produce multiply-spliced RNA coding for the Tat/Rev proteins. The objective of this study was to further optimize the assay by examining the influence of varied factors, such as the amount of products transferred from the pre-amplification step to the PCR reaction, storage of pre-amplification products prior to PCR runs, and the number of cells used, on the assay’s sensitivity and reproducibility. We also investigated whether the assay could be used to quantify HIV reservoirs in monocytes/macrophages. More... »

PAGES

2701-2710

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00705-018-3894-7

DOI

http://dx.doi.org/10.1007/s00705-018-3894-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1104458649

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29882046


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1108", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Microbiology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anti-Retroviral Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CD4-Positive T-Lymphocytes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "HIV Infections", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "HIV-1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Macrophages", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polymerase Chain Reaction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sensitivity and Specificity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Viral Load", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Virus Latency", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "rev Gene Products, Human Immunodeficiency Virus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "tat Gene Products, Human Immunodeficiency Virus", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "National HIV and Retrovirology Laboratories, National Microbiology Laboratory, JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, 1015 Arlington Street, R3E 3R2, Winnipeg, MB, Canada", 
          "id": "http://www.grid.ac/institutes/grid.415368.d", 
          "name": [
            "National HIV and Retrovirology Laboratories, National Microbiology Laboratory, JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, 1015 Arlington Street, R3E 3R2, Winnipeg, MB, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ch\u00e2tel", 
        "givenName": "Liam", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National HIV and Retrovirology Laboratories, National Microbiology Laboratory, JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, 1015 Arlington Street, R3E 3R2, Winnipeg, MB, Canada", 
          "id": "http://www.grid.ac/institutes/grid.415368.d", 
          "name": [
            "National HIV and Retrovirology Laboratories, National Microbiology Laboratory, JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, 1015 Arlington Street, R3E 3R2, Winnipeg, MB, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yang", 
        "givenName": "Xuefen", 
        "id": "sg:person.01204731664.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204731664.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National HIV and Retrovirology Laboratories, National Microbiology Laboratory, JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, 1015 Arlington Street, R3E 3R2, Winnipeg, MB, Canada", 
          "id": "http://www.grid.ac/institutes/grid.415368.d", 
          "name": [
            "National HIV and Retrovirology Laboratories, National Microbiology Laboratory, JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, 1015 Arlington Street, R3E 3R2, Winnipeg, MB, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cholette", 
        "givenName": "Fran\u00e7ois", 
        "id": "sg:person.015736305537.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015736305537.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Microbiology, Infectiology and Immunology, Faculty of Medicine, Universit\u00e9 de Montr\u00e9al, Montreal, QC, Canada", 
          "id": "http://www.grid.ac/institutes/grid.14848.31", 
          "name": [
            "Centre de recherche du Centre hospitalier universitaire Sainte-Justine, Montreal, QC, Canada", 
            "Department of Microbiology, Infectiology and Immunology, Faculty of Medicine, Universit\u00e9 de Montr\u00e9al, Montreal, QC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Soudeyns", 
        "givenName": "Hugo", 
        "id": "sg:person.01321765331.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01321765331.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National HIV and Retrovirology Laboratories, National Microbiology Laboratory, JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, 1015 Arlington Street, R3E 3R2, Winnipeg, MB, Canada", 
          "id": "http://www.grid.ac/institutes/grid.415368.d", 
          "name": [
            "National HIV and Retrovirology Laboratories, National Microbiology Laboratory, JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, 1015 Arlington Street, R3E 3R2, Winnipeg, MB, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sandstrom", 
        "givenName": "Paul", 
        "id": "sg:person.01022025746.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022025746.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National HIV and Retrovirology Laboratories, National Microbiology Laboratory, JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, 1015 Arlington Street, R3E 3R2, Winnipeg, MB, Canada", 
          "id": "http://www.grid.ac/institutes/grid.415368.d", 
          "name": [
            "National HIV and Retrovirology Laboratories, National Microbiology Laboratory, JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, 1015 Arlington Street, R3E 3R2, Winnipeg, MB, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lavigne", 
        "givenName": "Carole", 
        "id": "sg:person.01250164727.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01250164727.15"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s11904-016-0304-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020098334", 
          "https://doi.org/10.1007/s11904-016-0304-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13148-015-0137-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036461391", 
          "https://doi.org/10.1186/s13148-015-0137-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11904-014-0207-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018012117", 
          "https://doi.org/10.1007/s11904-014-0207-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/8394", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049869736", 
          "https://doi.org/10.1038/8394"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13365-014-0281-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037472978", 
          "https://doi.org/10.1007/s13365-014-0281-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12977-016-0323-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048725017", 
          "https://doi.org/10.1186/s12977-016-0323-4"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-06-07", 
    "datePublishedReg": "2018-06-07", 
    "description": "Antiretroviral therapy (ART) can lower a patient\u2019s HIV plasma viral load to an undetectable level, but following cessation of ART viremia rapidly rebounds. It has been shown that ART does not eliminate latent viruses sequestered into anatomical and cellular reservoirs. Therefore, in patients that have ceased ART, the following rebound in HIV viremia is caused by the activation of latent HIV reservoirs. A major issue in HIV cure research is the quantification of these latent HIV reservoirs. Various reservoir measurement methods exist, but the gold standard technique remains the culture-based quantitative viral outgrowth assay (QVOA). Recently, a new PCR-based assay, named the tat/rev induced limiting dilution assay (TILDA) was described which measures the frequency of inducible latently infected CD4+ T cells that actively produce multiply-spliced RNA coding for the Tat/Rev proteins. The objective of this study was to further optimize the assay by examining the influence of varied factors, such as the amount of products transferred from the pre-amplification step to the PCR reaction, storage of pre-amplification products prior to PCR runs, and the number of cells used, on the assay\u2019s sensitivity and reproducibility. We also investigated whether the assay could be used to quantify HIV reservoirs in monocytes/macrophages.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00705-018-3894-7", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1083335", 
        "issn": [
          "0304-8608", 
          "1432-8798"
        ], 
        "name": "Archives of Virology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "10", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "163"
      }
    ], 
    "keywords": [
      "latent HIV reservoir", 
      "antiretroviral therapy", 
      "HIV reservoir", 
      "Tat/Rev", 
      "quantitative viral outgrowth", 
      "HIV cure research", 
      "monocytes/macrophages", 
      "patients HIV", 
      "HIV viremia", 
      "viral outgrowth", 
      "viral load", 
      "cure research", 
      "cellular reservoirs", 
      "gold standard technique", 
      "T cells", 
      "latent virus", 
      "undetectable levels", 
      "number of cells", 
      "viremia", 
      "HIV", 
      "assay sensitivity", 
      "assays", 
      "dilution assays", 
      "pre-amplification step", 
      "standard techniques", 
      "Rev protein", 
      "CD4", 
      "cells", 
      "patients", 
      "therapy", 
      "new PCR", 
      "macrophages", 
      "cessation", 
      "sensitivity", 
      "virus", 
      "activation", 
      "PCR", 
      "outgrowth", 
      "PCR reaction", 
      "rebound", 
      "RNA", 
      "levels", 
      "factors", 
      "protein", 
      "study", 
      "Rev", 
      "PCR run", 
      "objective", 
      "frequency", 
      "varied factors", 
      "reproducibility", 
      "number", 
      "dilution", 
      "quantification", 
      "impact", 
      "major issue", 
      "products", 
      "reservoir", 
      "amount", 
      "research", 
      "reaction", 
      "conditions", 
      "technique", 
      "method", 
      "amount of product", 
      "influence", 
      "issues", 
      "measurement method", 
      "load", 
      "step", 
      "run", 
      "storage"
    ], 
    "name": "Impact of pre-amplification conditions on sensitivity of the tat/rev induced limiting dilution assay", 
    "pagination": "2701-2710", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1104458649"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00705-018-3894-7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29882046"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00705-018-3894-7", 
      "https://app.dimensions.ai/details/publication/pub.1104458649"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:44", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_757.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00705-018-3894-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00705-018-3894-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00705-018-3894-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00705-018-3894-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00705-018-3894-7'


 

This table displays all metadata directly associated to this object as RDF triples.

255 TRIPLES      21 PREDICATES      118 URIs      103 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00705-018-3894-7 schema:about N14b7cc0118404d388415d64c865d2e02
2 N24bd2682c1684ee9ba26a42d7b5a0dd2
3 N250435543b0b4980b6889d577c7ad59a
4 N4c25643cd5f448359adef560a3253979
5 N4ffc6933d47940ccbbcc9df7db9673b5
6 N6474dd078838412496a0dcfe962b0b76
7 N71385764990544c0af31f7e0eb6453e7
8 N780895be887644d29940dd39457282f2
9 N85b2403004444820a6cc765ceb44a99c
10 N961790acbe524417942527873c92b027
11 N9f3e773d1c844ae8862522ef962630be
12 Nd6bc921758464804923ed0e6057be09a
13 Ne8158f8faf414e2c8cfce75205bf611f
14 Nf43c887071d54f2e8a9960b2c22fc4bb
15 anzsrc-for:11
16 anzsrc-for:1103
17 anzsrc-for:1108
18 schema:author N5059ac33d6954c428824cd76df939f7a
19 schema:citation sg:pub.10.1007/s11904-014-0207-y
20 sg:pub.10.1007/s11904-016-0304-1
21 sg:pub.10.1007/s13365-014-0281-3
22 sg:pub.10.1038/8394
23 sg:pub.10.1186/s12977-016-0323-4
24 sg:pub.10.1186/s13148-015-0137-6
25 schema:datePublished 2018-06-07
26 schema:datePublishedReg 2018-06-07
27 schema:description Antiretroviral therapy (ART) can lower a patient’s HIV plasma viral load to an undetectable level, but following cessation of ART viremia rapidly rebounds. It has been shown that ART does not eliminate latent viruses sequestered into anatomical and cellular reservoirs. Therefore, in patients that have ceased ART, the following rebound in HIV viremia is caused by the activation of latent HIV reservoirs. A major issue in HIV cure research is the quantification of these latent HIV reservoirs. Various reservoir measurement methods exist, but the gold standard technique remains the culture-based quantitative viral outgrowth assay (QVOA). Recently, a new PCR-based assay, named the tat/rev induced limiting dilution assay (TILDA) was described which measures the frequency of inducible latently infected CD4+ T cells that actively produce multiply-spliced RNA coding for the Tat/Rev proteins. The objective of this study was to further optimize the assay by examining the influence of varied factors, such as the amount of products transferred from the pre-amplification step to the PCR reaction, storage of pre-amplification products prior to PCR runs, and the number of cells used, on the assay’s sensitivity and reproducibility. We also investigated whether the assay could be used to quantify HIV reservoirs in monocytes/macrophages.
28 schema:genre article
29 schema:isAccessibleForFree false
30 schema:isPartOf Ne677570ba56d48c793cc84f753ae6329
31 Nfd3c09e92c2d4e65ae15d1d4613033fa
32 sg:journal.1083335
33 schema:keywords CD4
34 HIV
35 HIV cure research
36 HIV reservoir
37 HIV viremia
38 PCR
39 PCR reaction
40 PCR run
41 RNA
42 Rev
43 Rev protein
44 T cells
45 Tat/Rev
46 activation
47 amount
48 amount of product
49 antiretroviral therapy
50 assay sensitivity
51 assays
52 cells
53 cellular reservoirs
54 cessation
55 conditions
56 cure research
57 dilution
58 dilution assays
59 factors
60 frequency
61 gold standard technique
62 impact
63 influence
64 issues
65 latent HIV reservoir
66 latent virus
67 levels
68 load
69 macrophages
70 major issue
71 measurement method
72 method
73 monocytes/macrophages
74 new PCR
75 number
76 number of cells
77 objective
78 outgrowth
79 patients
80 patients HIV
81 pre-amplification step
82 products
83 protein
84 quantification
85 quantitative viral outgrowth
86 reaction
87 rebound
88 reproducibility
89 research
90 reservoir
91 run
92 sensitivity
93 standard techniques
94 step
95 storage
96 study
97 technique
98 therapy
99 undetectable levels
100 varied factors
101 viral load
102 viral outgrowth
103 viremia
104 virus
105 schema:name Impact of pre-amplification conditions on sensitivity of the tat/rev induced limiting dilution assay
106 schema:pagination 2701-2710
107 schema:productId N114f74275b0242ebb16e1d282dbb7a9e
108 N3815cc6a19a94d27801804ae46049880
109 Nf9ffc81964494f319046e80b23fdd03f
110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104458649
111 https://doi.org/10.1007/s00705-018-3894-7
112 schema:sdDatePublished 2022-10-01T06:44
113 schema:sdLicense https://scigraph.springernature.com/explorer/license/
114 schema:sdPublisher Nfc607314c2344404b7eeea66bb2fdc9c
115 schema:url https://doi.org/10.1007/s00705-018-3894-7
116 sgo:license sg:explorer/license/
117 sgo:sdDataset articles
118 rdf:type schema:ScholarlyArticle
119 N114f74275b0242ebb16e1d282dbb7a9e schema:name doi
120 schema:value 10.1007/s00705-018-3894-7
121 rdf:type schema:PropertyValue
122 N14b7cc0118404d388415d64c865d2e02 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name HIV Infections
124 rdf:type schema:DefinedTerm
125 N24bd2682c1684ee9ba26a42d7b5a0dd2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Viral Load
127 rdf:type schema:DefinedTerm
128 N250435543b0b4980b6889d577c7ad59a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name HIV-1
130 rdf:type schema:DefinedTerm
131 N2fc6bf2af6694e17ad6b7351b62a2f93 rdf:first sg:person.015736305537.72
132 rdf:rest Nc2f138d309fc4e318f35d48ce0f32afd
133 N3815cc6a19a94d27801804ae46049880 schema:name pubmed_id
134 schema:value 29882046
135 rdf:type schema:PropertyValue
136 N419eaf9106854aeb8d27c30f94f19d9d schema:affiliation grid-institutes:grid.415368.d
137 schema:familyName Châtel
138 schema:givenName Liam
139 rdf:type schema:Person
140 N4c25643cd5f448359adef560a3253979 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name tat Gene Products, Human Immunodeficiency Virus
142 rdf:type schema:DefinedTerm
143 N4ffc6933d47940ccbbcc9df7db9673b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Sensitivity and Specificity
145 rdf:type schema:DefinedTerm
146 N5059ac33d6954c428824cd76df939f7a rdf:first N419eaf9106854aeb8d27c30f94f19d9d
147 rdf:rest Ndee8cb1d8b434d4f8e15650ff35937e5
148 N6474dd078838412496a0dcfe962b0b76 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name rev Gene Products, Human Immunodeficiency Virus
150 rdf:type schema:DefinedTerm
151 N71385764990544c0af31f7e0eb6453e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Virus Latency
153 rdf:type schema:DefinedTerm
154 N780895be887644d29940dd39457282f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name CD4-Positive T-Lymphocytes
156 rdf:type schema:DefinedTerm
157 N85b2403004444820a6cc765ceb44a99c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name RNA, Viral
159 rdf:type schema:DefinedTerm
160 N95a8d802fbfd4518a72198334725ffe6 rdf:first sg:person.01022025746.90
161 rdf:rest Ncc9a0e756973479fa8d654ba745ce43d
162 N961790acbe524417942527873c92b027 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Humans
164 rdf:type schema:DefinedTerm
165 N9f3e773d1c844ae8862522ef962630be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Polymerase Chain Reaction
167 rdf:type schema:DefinedTerm
168 Nc2f138d309fc4e318f35d48ce0f32afd rdf:first sg:person.01321765331.58
169 rdf:rest N95a8d802fbfd4518a72198334725ffe6
170 Ncc9a0e756973479fa8d654ba745ce43d rdf:first sg:person.01250164727.15
171 rdf:rest rdf:nil
172 Nd6bc921758464804923ed0e6057be09a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Anti-Retroviral Agents
174 rdf:type schema:DefinedTerm
175 Ndee8cb1d8b434d4f8e15650ff35937e5 rdf:first sg:person.01204731664.74
176 rdf:rest N2fc6bf2af6694e17ad6b7351b62a2f93
177 Ne677570ba56d48c793cc84f753ae6329 schema:issueNumber 10
178 rdf:type schema:PublicationIssue
179 Ne8158f8faf414e2c8cfce75205bf611f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Macrophages
181 rdf:type schema:DefinedTerm
182 Nf43c887071d54f2e8a9960b2c22fc4bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Cell Line
184 rdf:type schema:DefinedTerm
185 Nf9ffc81964494f319046e80b23fdd03f schema:name dimensions_id
186 schema:value pub.1104458649
187 rdf:type schema:PropertyValue
188 Nfc607314c2344404b7eeea66bb2fdc9c schema:name Springer Nature - SN SciGraph project
189 rdf:type schema:Organization
190 Nfd3c09e92c2d4e65ae15d1d4613033fa schema:volumeNumber 163
191 rdf:type schema:PublicationVolume
192 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
193 schema:name Medical and Health Sciences
194 rdf:type schema:DefinedTerm
195 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
196 schema:name Clinical Sciences
197 rdf:type schema:DefinedTerm
198 anzsrc-for:1108 schema:inDefinedTermSet anzsrc-for:
199 schema:name Medical Microbiology
200 rdf:type schema:DefinedTerm
201 sg:journal.1083335 schema:issn 0304-8608
202 1432-8798
203 schema:name Archives of Virology
204 schema:publisher Springer Nature
205 rdf:type schema:Periodical
206 sg:person.01022025746.90 schema:affiliation grid-institutes:grid.415368.d
207 schema:familyName Sandstrom
208 schema:givenName Paul
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022025746.90
210 rdf:type schema:Person
211 sg:person.01204731664.74 schema:affiliation grid-institutes:grid.415368.d
212 schema:familyName Yang
213 schema:givenName Xuefen
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204731664.74
215 rdf:type schema:Person
216 sg:person.01250164727.15 schema:affiliation grid-institutes:grid.415368.d
217 schema:familyName Lavigne
218 schema:givenName Carole
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01250164727.15
220 rdf:type schema:Person
221 sg:person.01321765331.58 schema:affiliation grid-institutes:grid.14848.31
222 schema:familyName Soudeyns
223 schema:givenName Hugo
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01321765331.58
225 rdf:type schema:Person
226 sg:person.015736305537.72 schema:affiliation grid-institutes:grid.415368.d
227 schema:familyName Cholette
228 schema:givenName François
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015736305537.72
230 rdf:type schema:Person
231 sg:pub.10.1007/s11904-014-0207-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1018012117
232 https://doi.org/10.1007/s11904-014-0207-y
233 rdf:type schema:CreativeWork
234 sg:pub.10.1007/s11904-016-0304-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020098334
235 https://doi.org/10.1007/s11904-016-0304-1
236 rdf:type schema:CreativeWork
237 sg:pub.10.1007/s13365-014-0281-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037472978
238 https://doi.org/10.1007/s13365-014-0281-3
239 rdf:type schema:CreativeWork
240 sg:pub.10.1038/8394 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049869736
241 https://doi.org/10.1038/8394
242 rdf:type schema:CreativeWork
243 sg:pub.10.1186/s12977-016-0323-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048725017
244 https://doi.org/10.1186/s12977-016-0323-4
245 rdf:type schema:CreativeWork
246 sg:pub.10.1186/s13148-015-0137-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036461391
247 https://doi.org/10.1186/s13148-015-0137-6
248 rdf:type schema:CreativeWork
249 grid-institutes:grid.14848.31 schema:alternateName Department of Microbiology, Infectiology and Immunology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada
250 schema:name Centre de recherche du Centre hospitalier universitaire Sainte-Justine, Montreal, QC, Canada
251 Department of Microbiology, Infectiology and Immunology, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada
252 rdf:type schema:Organization
253 grid-institutes:grid.415368.d schema:alternateName National HIV and Retrovirology Laboratories, National Microbiology Laboratory, JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, 1015 Arlington Street, R3E 3R2, Winnipeg, MB, Canada
254 schema:name National HIV and Retrovirology Laboratories, National Microbiology Laboratory, JC Wilt Infectious Diseases Research Centre, Public Health Agency of Canada, 1015 Arlington Street, R3E 3R2, Winnipeg, MB, Canada
255 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...